BRCA2 and breast cancer: The results of the comparison of the breast cancer subtypes between the three groups were as follows: triple-negative breast cancer accounted for 89% of the BRCA1 L63X mutation group, 64.4% of other BRCA1 group, and 21.2% of BRCA2 group (p < 0.001).